How to Improve Healthcare for Patients with Multimorbidity and Polypharmacy in Primary Care: A Pragmatic Cluster-Randomized Clinical Trial of the MULTIPAP Intervention

Del Cura-Gonzalez I, Lopez-Rodriguez JA, Leiva-Fernandez F, Gimeno-Miguel A, Poblador-Plou B, Lopez-Verde F, Lozano-Hernandez C, Pico-Soler V, Bujalance-Zafra MJ, Gimeno-Feliu LA, Aza-Pascual-Salcedo M, et al. (2022)
Journal of Personalized Medicine 12(5): 752.

Zeitschriftenaufsatz | Veröffentlicht | Englisch
 
Download
OA 719.39 KB
Autor*in
Del Cura-Gonzalez, Isabel; Lopez-Rodriguez, Juan A.; Leiva-Fernandez, Francisca; Gimeno-Miguel, Antonio; Poblador-Plou, Beatriz; Lopez-Verde, Fernando; Lozano-Hernandez, Cristina; Pico-Soler, Victoria; Bujalance-Zafra, Ma Josefa; Gimeno-Feliu, Luis A.; Aza-Pascual-Salcedo, Mercedes; Rogero-Blanco, Marisa
Alle
Abstract / Bemerkung
(1) Purpose: To investigate a complex MULTIPAP intervention that implements the Ariadne principles in a primary care population of young-elderly patients with multimorbidity and polypharmacy and to evaluate its effectiveness for improving the appropriateness of prescriptions. (2) Methods: A pragmatic cluster-randomized clinical trial was conducted involving 38 family practices in Spain. Patients aged 65-74 years with multimorbidity and polypharmacy were recruited. Family physicians (FPs) were randomly allocated to continue usual care or to provide the MULTIPAP intervention based on the Ariadne principles with two components: FP training (eMULTIPAP) and FP patient interviews. The primary outcome was the appropriateness of prescribing, measured as the between-group difference in the mean Medication Appropriateness Index (MAI) score change from the baseline to the 6-month follow-up. The secondary outcomes were quality of life (EQ-5D-5L), patient perceptions of shared decision making (collaboRATE), use of health services, treatment adherence, and incidence of drug adverse events (all at 1 year), using multi-level regression models, with FP as a random effect. (3) Results: We recruited 117 FPs and 593 of their patients. In the intention-to-treat analysis, the between-group difference for the mean MAI score change after a 6-month follow-up was -2.42 (95% CI from -4.27 to -0.59) and, between baseline and a 12-month follow-up was -3.40 (95% CI from -5.45 to -1.34). There were no significant differences in any other secondary outcomes. (4) Conclusions: The MULTIPAP intervention improved medication appropriateness sustainably over the follow-up time. The small magnitude of the effect, however, advises caution in the interpretation of the results given the paucity of evidence for the clinical benefit of the observed change in the MAI.
Stichworte
multimorbidity; polypharmacy; Ariadne principles
Erscheinungsjahr
2022
Zeitschriftentitel
Journal of Personalized Medicine
Band
12
Ausgabe
5
Art.-Nr.
752
eISSN
2075-4426
Page URI
https://pub.uni-bielefeld.de/record/2963833

Zitieren

Del Cura-Gonzalez I, Lopez-Rodriguez JA, Leiva-Fernandez F, et al. How to Improve Healthcare for Patients with Multimorbidity and Polypharmacy in Primary Care: A Pragmatic Cluster-Randomized Clinical Trial of the MULTIPAP Intervention. Journal of Personalized Medicine . 2022;12(5): 752.
Del Cura-Gonzalez, I., Lopez-Rodriguez, J. A., Leiva-Fernandez, F., Gimeno-Miguel, A., Poblador-Plou, B., Lopez-Verde, F., Lozano-Hernandez, C., et al. (2022). How to Improve Healthcare for Patients with Multimorbidity and Polypharmacy in Primary Care: A Pragmatic Cluster-Randomized Clinical Trial of the MULTIPAP Intervention. Journal of Personalized Medicine , 12(5), 752. https://doi.org/10.3390/jpm12050752
Del Cura-Gonzalez, I., Lopez-Rodriguez, J. A., Leiva-Fernandez, F., Gimeno-Miguel, A., Poblador-Plou, B., Lopez-Verde, F., Lozano-Hernandez, C., Pico-Soler, V., Bujalance-Zafra, M. J., Gimeno-Feliu, L. A., et al. (2022). How to Improve Healthcare for Patients with Multimorbidity and Polypharmacy in Primary Care: A Pragmatic Cluster-Randomized Clinical Trial of the MULTIPAP Intervention. Journal of Personalized Medicine 12:752.
Del Cura-Gonzalez, I., et al., 2022. How to Improve Healthcare for Patients with Multimorbidity and Polypharmacy in Primary Care: A Pragmatic Cluster-Randomized Clinical Trial of the MULTIPAP Intervention. Journal of Personalized Medicine , 12(5): 752.
I. Del Cura-Gonzalez, et al., “How to Improve Healthcare for Patients with Multimorbidity and Polypharmacy in Primary Care: A Pragmatic Cluster-Randomized Clinical Trial of the MULTIPAP Intervention”, Journal of Personalized Medicine , vol. 12, 2022, : 752.
Del Cura-Gonzalez, I., Lopez-Rodriguez, J.A., Leiva-Fernandez, F., Gimeno-Miguel, A., Poblador-Plou, B., Lopez-Verde, F., Lozano-Hernandez, C., Pico-Soler, V., Bujalance-Zafra, M.J., Gimeno-Feliu, L.A., Aza-Pascual-Salcedo, M., Rogero-Blanco, M., Gonzalez-Rubio, F., Garcia-de-Blas, F., Polentinos-Castro, E., Sanz-Cuesta, T., Castillo-Jimena, M., Alonso-Garcia, M., Calderon-Larranaga, A., Valderas, J.M., Marengoni, A., Muth, C., Prados-Torres, J.D., Prados-Torres, A.: How to Improve Healthcare for Patients with Multimorbidity and Polypharmacy in Primary Care: A Pragmatic Cluster-Randomized Clinical Trial of the MULTIPAP Intervention. Journal of Personalized Medicine . 12, : 752 (2022).
Del Cura-Gonzalez, Isabel, Lopez-Rodriguez, Juan A., Leiva-Fernandez, Francisca, Gimeno-Miguel, Antonio, Poblador-Plou, Beatriz, Lopez-Verde, Fernando, Lozano-Hernandez, Cristina, Pico-Soler, Victoria, Bujalance-Zafra, Ma Josefa, Gimeno-Feliu, Luis A., Aza-Pascual-Salcedo, Mercedes, Rogero-Blanco, Marisa, Gonzalez-Rubio, Francisca, Garcia-de-Blas, Francisca, Polentinos-Castro, Elena, Sanz-Cuesta, Teresa, Castillo-Jimena, Marcos, Alonso-Garcia, Marcos, Calderon-Larranaga, Amaia, Valderas, Jose M., Marengoni, Alessandra, Muth, Christiane, Prados-Torres, Juan Daniel, and Prados-Torres, Alexandra. “How to Improve Healthcare for Patients with Multimorbidity and Polypharmacy in Primary Care: A Pragmatic Cluster-Randomized Clinical Trial of the MULTIPAP Intervention”. Journal of Personalized Medicine 12.5 (2022): 752.
Alle Dateien verfügbar unter der/den folgenden Lizenz(en):
Creative Commons Namensnennung 4.0 International Public License (CC-BY 4.0):
Volltext(e)
Name
Access Level
OA Open Access
Zuletzt Hochgeladen
2022-07-06T10:11:46Z
MD5 Prüfsumme
326161fa8bfc85a00cd4af3e58cc83f0

Link(s) zu Volltext(en)
Access Level
OA Open Access

Export

Markieren/ Markierung löschen
Markierte Publikationen

Open Data PUB

Web of Science

Dieser Datensatz im Web of Science®

Quellen

PMID: 35629175
PubMed | Europe PMC

Suchen in

Google Scholar